IRMD
IRMD
NASDAQ · Health Care

Iradimed Corp

$85.54
-3.04 (-3.43%)
Financial Highlights (FY 2026)
Revenue
83.38M
Net Income
22.36M
Gross Margin
76.7%
Profit Margin
26.8%
Rev Growth
+16.3%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.7% 76.7% 64.3% 64.3%
Operating Margin 31.2% 28.1% 20.9% 21.7%
Profit Margin 26.8% 25.5% 19.7% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 83.38M 71.70M 371.28M 367.15M
Gross Profit 63.99M 55.03M 238.61M 235.95M
Operating Income 26.01M 20.13M 77.66M 79.60M
Net Income 22.36M 17.31M 73.06M 68.53M
Gross Margin 76.7% 76.7% 64.3% 64.3%
Operating Margin 31.2% 28.1% 20.9% 21.7%
Profit Margin 26.8% 25.5% 19.7% 18.7%
Rev Growth +16.3% +16.3% +3.1% +13.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 192.97M 209.74M
Total Equity — — 936.02M 858.01M
D/E Ratio — — 0.21 0.24
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 27.17M 22.20M 107.10M 104.64M
Free Cash Flow — — 59.94M 58.81M